… induction treatment period in the ongoing Phase 2b REZOLVE-AA clinical trial … -stage biotechnology company focused on developing treatments that address the underlying immunological … in one Phase 2 clinical trial in Type 1 diabetes mellitus. Nektar's …

… voucher. When a treatment demonstrates outstanding trial results, we have … a new era in treating multiple myeloma with the … CNPV program. The other drugs granted vouchers to date … for infertility Teplizumab for Type I diabetes Cytisinicline for nicotine vaping …

… development risk in patients with T2D. By integrating clinical outcomes, drug … a diagnosis of type 1 diabetes or any other … received standard antidiabetic treatments, including metformin, sulfonylureas … therapeutic potential. Front Pharmacol. 2024;15:1369352 …

… increasing the risk for adverse drug reactions and complicating the management … for collaborative medication reviews with an interdisciplinary team, including pharmacists, to … Population with Type 1 Diabetes: A Narrative Review. J GEN INTERN MED (2025). …

… warrants integration into holistic treatment regimens. Tailoring interventions to … researchers can propel the development of innovative, individualized therapies … with Type 1 Diabetes Article Title: Sleep heterogeneity in adolescents with type 1 diabetes: …

… lifestyle changes, and more.While Type 1 Diabetes (T1D) is an autoimmune … says For decades, medical treatments have focused mainly on … weight loss simultaneously. These medications work by mimicking a … being very effective in treating obesity and diabetes.But …

… Offers New Hope for Type 1 Diabetes Scientists have successfully … of “Innovations In: Type 1 Diabetes,” an editorially independent special … opens exciting possibilities for treating diabetes and other … take strong immune-suppressing drugs for life, which …

… kidney disease and type 1 diabetes. The trial used albuminuria as … pharmacologist in the department of clinical pharmacy and pharmacology … between treatment effects on albuminuria and treatment effects … generate new evidence about drug efficacy and safety. …

… earliest stages of T1D development. The implications of … revolutionize early-stage T1D treatment. Notably, the researchers … could identify novel drug targets to modulate … into immune tolerance collapsepediatric type 1 diabetes researchregulatory T cell …

… leverage these biomarkers to tailor treatment strategies for individuals based on … could lead to the development of drugs designed to modulate microRNA functions … for groundbreaking developments in the understanding and management of type 1 diabetes. As the …